UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 6
June-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1906253


Registration ID:
214141

Page Number

754-759

Share This Article


Jetir RMS

Title

DEVELOPMENT AND VALIDATION OF ADAPALENE AND DAPSONE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC AND ITS DEGRADATION

Abstract

The present paper describes a simple, accurate and precise reversed phase High Performance Liquid Chromatography (HPLC) method for rapid and simultaneous quantification of Adapalene and Dapsone. The chromatographic separation was achieved on X-Bridge C8 (150x4.6mm, 3.5µ) column. Mobile phase contained a mixture of 1mg Hexane Sulphonic acid of pH=5.0 adjusted with OPA is used as buffer and Acetonitrile in the ratio of 40:60 v/v, flow rate 1.0ml/min and UV detection at 249nm. The proposed method shows a good linearity in the concentration range of 1-15µg/ml of Adapalene and 50-750µg/ml of Dapsone under optimized conditions. Precision and recovery study results are in between 98-102%. In the entire robustness conditions %RSD is below 2.0%. Degradation has minimum effect in stress condition and solutions are stable up to 24hrs. This method is validated for different parameters like Precision, linearity, accuracy, limit of detection (LOD), limit of quantification (LOQ), ruggedness, robustness and forced degradation study were determined according to the ICH Q2B guidelines. All the parameters of validation were found to be within the acceptance range of ICH guidelines.

Key Words

RP-HPLC, Adapalene and Dapsone

Cite This Article

"DEVELOPMENT AND VALIDATION OF ADAPALENE AND DAPSONE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC AND ITS DEGRADATION", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.754-759, June-2019, Available :http://www.jetir.org/papers/JETIR1906253.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DEVELOPMENT AND VALIDATION OF ADAPALENE AND DAPSONE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC AND ITS DEGRADATION", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp754-759, June-2019, Available at : http://www.jetir.org/papers/JETIR1906253.pdf

Publication Details

Published Paper ID: JETIR1906253
Registration ID: 214141
Published In: Volume 6 | Issue 6 | Year June-2019
DOI (Digital Object Identifier):
Page No: 754-759
Country: Vijayawada, Andhra Pradesh, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002867

Print This Page

Current Call For Paper

Jetir RMS